1. Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82–90]. (October 2017) Authors: Eggink, F.A.; Mom, C.H.; Bouwman, K.; Boll, D.; Becker, J.H.; Creutzberg, C.L.; Niemeijer, G.C.; van Driel, W.J.; Reyners, A.K.; van der Zee, A.G.; Bremer, G.L.; Ezendam, N.P.; Kruitwagen, R.F.; Pijnenborg, J.M.; Hollema, H.; Nijman, H.W.; van der Aa, M.A. Journal: European journal of cancer Issue: Volume 84(2017) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification. (June 2017) Authors: Eggink, F.A.; Mom, C.H.; Bouwman, K.; Boll, D.; Becker, J.H.; Creutzberg, C.L.; Niemeijer, G.C.; van Driel, W.J.; Reyners, A.K.; van der Zee, A.G.; Bremer, G.L.; Ezendam, N.P.; Kruitwagen, R.F.; Pijnenborg, J.M.; Hollema, H.; Nijman, H.W.; van der Aa, M.A. Journal: European journal of cancer Issue: Volume 78(2017) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0323: Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer. (April 2018) Authors: De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; Colombo, A.; Fyles, A.; Baron, M.H.; Jürgenliemk-Schulz, I.M.; Kitchener, H.C.; Nijman, H.W.; Wilson, G.; Kolodziej, I.; Carinelli, S.; Lutgens, L.C.H.W.; Smit, V.T... Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3. (November 2020) Authors: Post, C.; De Boer, S.M.; Powell, M.E.; Mileshkin, L.; Katsaros, D.; Bessette, P.; Haie-Meder, C.; Ottevanger, P.B.; Ledermann, J.A.; Khaw, P.; D'Amico, R.; Fyles, A.; Baron, M.; Kitchener, H.C.; Nijman, H.W.; Lutgens, L.C.; Brooks, S.; Jürgenliemk-Schulz, I.M.; Feeney, A.; Nout, R.A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial. (April 2015) Authors: De Boer, S.M.; Nout, R.A.; Putter, H.; Jürgenliemk-Schulz, I.M.; Jobsen, J.J.; Lutgens, L.C.H.W.; Van der Steen-Banasik, E.M.; Mens, J.W.M.; Slot, A.; Stenfert Kroese, M.C.; Nijman, H.W.; Creutzberg, C.L. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment. (November 2017) Authors: Versluis, M.A.C.; Marchal, S.; Plat, A.; de Bock, G.H.; van Hall, T.; de Bruyn, M.; Hollema, H.; Nijman, H.W. Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗